Loading clinical trials...
Loading clinical trials...
A Double Blind, Two Arm, Multicenter, Randomized, Parallel Group, Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies
Conditions
Interventions
Permethrin Cream 5%
Locations
5
United States
Universal Biopharma Research Institute Inc.
Dinuba, California, United States
Long Beach Clinical Trials Services, Inc.
Long Beach, California, United States
Havana Research Institute
Pasadena, California, United States
SouthCoast Research Center, Inc (Clinical Site & Drug Shipment Facility)
Miami, Florida, United States
West Houston Clinical Research Service
Houston, Texas, United States
Start Date
April 10, 2018
Primary Completion Date
November 13, 2018
Completion Date
December 6, 2018
Last Updated
October 23, 2020
NCT07305961
NCT06896929
NCT02841215
NCT02094716
NCT05819983
NCT05271968
Lead Sponsor
Saptalis Pharmaceuticals LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions